NuScale
SMR
$10.48
-6.68%
NuScale Power Corporation is a pre-revenue, development-stage company pioneering small modular reactor (SMR) technology designed to provide safe, scalable, and carbon-free nuclear power. It is a pure-play technology developer and licensor in the advanced nuclear energy sector, aiming to commercialize its proprietary NuScale Power Module. The current investor narrative is intensely focused on its challenging path to commercialization, characterized by significant quarterly revenue misses, escalating R&D spending, and substantial cash burn, which has led to a dramatic stock price decline and raised questions about its funding runway and ability to secure first-of-a-kind projects.…
SMR
NuScale
$10.48
Related headlines
Investment Opinion: Should I buy SMR Today?
Rating: Hold. The core thesis is that NuScale is a high-risk, binary-outcome speculation where current financials justify extreme caution, but the long-term optionality on SMR commercialization prevents a full Sell recommendation for risk-tolerant investors.
The Hold rating is supported by four specific data points: 1) The astronomical 73.7x P/S ratio shows the stock is priced for perfection, leaving no margin for error. 2) Revenue growth is currently negative (-94.7% YoY), not positive, contradicting a growth investment thesis. 3) Profitability metrics are deeply negative, with a net margin of -11.3% and ROE of -30.4%, indicating value destruction. 4) Analyst sentiment is predominantly neutral-to-negative, with no clear consensus price target to provide valuation support.
The two biggest risks invalidating a Hold are 1) a further deceleration in securing project awards, leading to cash burn concerns, and 2) a breakdown below the $8.85 support level, signaling total loss of technical confidence. This Hold would upgrade to a speculative Buy only on confirmation of a major, funded project contract with a credible partner. It would downgrade to a Sell on a sustained break below $8.85 or an announcement of a dilutive capital raise. The stock is overvalued on any traditional metric but may be fairly valued as a long-dated, high-volatility call option on SMR technology.
Sign up to view all
SMR 12-Month Price Forecast
The outlook is bifurcated between a distant potential boom and persistent near-term bust. The high cash balance prevents an immediate crisis, but the catastrophic revenue trend and extreme valuation create a fragile equilibrium. The most likely path (Base Case, 50% probability) is continued volatility within a lower range, as the company works to convert interest into firm orders. The stance is neutral because the risk of further decline to the $8.85 support is balanced by the possibility of a sentiment-driven bounce on any positive news. This neutral stance would upgrade to bullish only on concrete evidence of order conversion and funding. It would downgrade to bearish on a break below $8.85 or a guidance reduction for the commercialization timeline.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on NuScale's 12-month outlook, with a consensus price target around $13.62 and implied upside of +30.0% versus the current price.
Average Target
$13.62
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$8 - $14
Analyst target range
Analyst coverage is limited, with data indicating 6 analysts providing estimates, but no explicit consensus price target, recommendation breakdown, or target range is provided in the dataset. The institutional ratings data shows a recent pattern of reiterated 'Neutral', 'Sell', and 'Sector Perform' ratings from firms like UBS, Citigroup, RBC Capital, and Goldman Sachs in Q1 2026, with only Canaccord Genuity and Cantor Fitzgerald maintaining 'Buy' or 'Overweight' stances. The absence of a clear consensus target and the prevalence of neutral-to-negative ratings signal high uncertainty and a lack of bullish conviction among institutional analysts. This limited and cautious coverage is typical for a pre-revenue, development-stage company like NuScale, where the binary outcome of technology success or failure leads to high volatility and inefficient price discovery, as the stock price is driven more by sentiment and news flow than fundamental metrics.
Bulls vs Bears: SMR Investment Factors
The bear case currently holds stronger evidence, grounded in catastrophic quarterly revenue declines, unsustainable cash burn, and a severe technical breakdown. The bull thesis rests entirely on future commercialization success, which is not yet evidenced in financials. The single most important tension is between the company's robust $841.5 million cash balance, which provides a multi-year runway, and its aggressive -$460.1 million annual cash burn rate, which threatens that runway if commercialization milestones are not met on schedule. The investment debate hinges on whether NuScale can bridge this gap with a major project win before liquidity concerns resurface.
Bullish
- Strong Cash Runway: The company ended Q4 2025 with $841.5 million in cash and no debt, providing a significant liquidity buffer. With a current ratio of 4.3, near-term solvency is not a concern, allowing continued R&D investment.
- Massive Analyst Revenue Growth Forecast: Analysts project average revenue of $1.31 billion for the next fiscal year, representing exponential growth from the current $1.8 million quarterly run rate. This reflects market expectations for a successful commercial breakthrough.
- Pure-Play on High-Demand SMR Technology: As a pure-play licensor of small modular reactor technology, NuScale is positioned in the high-growth, carbon-free energy sector. The narrative of energy security and AI power demand provides a powerful long-term tailwind.
- Valuation Compression from Extreme Highs: The stock's price has fallen 53% over the past year and its P/S ratio has compressed from over 1,200x to 73.7x. This dramatic decline may have priced in significant near-term disappointment, reducing downside risk from current levels.
Bearish
- Catastrophic Revenue Collapse: Q4 2025 revenue collapsed 94.7% year-over-year to just $1.8 million, highlighting the erratic, project-based nature of current income. This underscores the severe challenge in generating sustainable revenue streams before commercialization.
- Unsustainable Cash Burn: Trailing twelve-month free cash flow is deeply negative at -$460.1 million. Despite a large cash balance, this burn rate threatens the funding runway if commercialization timelines slip further, risking future dilution.
- Extreme Valuation with No Earnings: The stock trades at a trailing P/S of 73.7x and a forward P/E of -18.3, indicating the market is pricing in flawless future execution. Any delay or cost overrun could trigger severe multiple compression given the lack of earnings support.
- Severe Technical Downtrend & High Volatility: The stock is down 50% over six months, trades just 27% above its 52-week low, and has a beta of 2.25. This indicates overwhelming selling pressure, 'falling knife' risk, and amplified downside moves relative to the market.
SMR Technical Analysis
The stock is in a severe and sustained downtrend, having declined 53.21% over the past year and nearly 50% over the last six months, with a maximum drawdown of -82.86%. Currently trading at $11.23, it sits just 27% above its 52-week low of $8.85, placing it in the lower quartile of its annual range; this positioning reflects deep-seated bearish sentiment and suggests the stock is in 'falling knife' territory, where attempts to catch a bottom are extremely risky. The 1-month and 3-month price changes of -4.10% and -21.52%, respectively, indicate that the negative momentum has persisted and even accelerated recently, diverging sharply from the S&P 500's positive returns over the same periods (SPY +5.6% and +8.42%). This pronounced underperformance, evidenced by a 1-year relative strength of -78.40%, signals overwhelming selling pressure and a lack of positive catalysts. Key technical levels are clear: the 52-week high of $57.42 serves as distant resistance, while the $8.85 low is critical support; a sustained breakdown below this support could trigger a new leg down. With a beta of 2.25, the stock is over twice as volatile as the broader market, amplifying both downside risk and potential upside but currently reflecting extreme speculative stress and high uncertainty around the company's future.
Beta
2.25
2.25x market volatility
Max Drawdown
-82.9%
Largest decline past year
52-Week Range
$9-$57
Price range past year
Annual Return
-56.6%
Cumulative gain past year
| Period | SMR Return | S&P 500 |
|---|---|---|
| 1m | -17.2% | +4.0% |
| 3m | -26.6% | +8.2% |
| 6m | -50.4% | +11.5% |
| 1y | -56.6% | +24.3% |
| ytd | -35.7% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SMR Fundamental Analysis
Revenue is minimal and highly erratic, with the most recent Q4 2025 figure at just $1.8 million, representing a staggering 94.7% year-over-year decline from $34.2 million in Q4 2024; this collapse highlights the project-based, non-recurring nature of its current income and the severe challenges in generating sustainable revenue streams. The company is deeply unprofitable, reporting a Q4 2025 net loss of $50.8 million and an operating margin of -40.2%, while gross margin turned negative at -3.4%, indicating its cost of revenue currently exceeds its minimal sales. The trend in losses is concerning, as the net loss widened significantly from $17.4 million in Q3 2024 to $273.3 million in Q3 2025, before narrowing to the $50.8 million loss in the latest quarter, but the path to profitability remains distant given the massive ongoing R&D and G&A expenses. Financially, the company is burning cash aggressively, with trailing twelve-month free cash flow deeply negative at -$460.1 million, though it ended Q4 2025 with a cash balance of $841.5 million providing a runway. The balance sheet shows no debt (debt-to-equity of 0) and a strong current ratio of 4.3, indicating ample liquidity in the near term, but the core challenge is the unsustainable cash burn rate against its market cap of $5.17 billion, with a Return on Equity of -30.4% underscoring destructive shareholder value erosion.
Quarterly Revenue
$1808000.0B
2025-12
Revenue YoY Growth
-0.94%
YoY Comparison
Gross Margin
-0.03%
Latest Quarter
Free Cash Flow
$-460117999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SMR Overvalued?
Given the company's consistent and substantial net losses, the primary valuation metric is the Price-to-Sales (PS) ratio. The trailing PS ratio is an astronomically high 73.7x, while the forward PS ratio is not calculable from the data but implied to be high given minimal estimated revenue. This extreme multiple reflects a market valuation entirely predicated on future commercialization success rather than current financials. Peer comparison is challenging due to its unique pre-revenue status, but such a PS ratio represents a massive premium to any established utility or energy company, pricing in a flawless and rapid commercial rollout. Historically, the stock's own valuation has compressed dramatically from a PS ratio of over 1,200x in late 2025 to the current 73.7x, yet it remains near the top of its own historical PS band for recent quarters, suggesting the market is still assigning a significant, though diminished, option value to its technology despite the severe operational and financial headwinds. The negative trailing PE of -6.5 and forward PE of -18.3 further emphasize the lack of earnings, making traditional profitability-based metrics meaningless.
PE
-6.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -75x~-3x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-6.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company's revenue collapsed 94.7% YoY in Q4 2025 to $1.8 million, demonstrating an unreliable, non-recurring income model. With a trailing FCF burn of -$460.1 million and an operating margin of -40.2%, the path to profitability is distant. While the $841.5 million cash balance provides a runway, the current burn rate implies a finite timeline of under two years to achieve a revenue inflection, creating high execution risk and potential for dilutive capital raises.
Market & Competitive Risks stem from an extreme valuation disconnected from fundamentals. The trailing P/S of 73.7x prices in flawless execution and represents a massive premium to any utility peer. With a beta of 2.25, the stock is hypersensitive to market sentiment and risk-off moves. Competitive risks are high, as seen in recent news where UK funding benefited competitor Rolls-Royce more than NuScale. The stock's -78.4% 1-year relative strength indicates it is being abandoned by the market, increasing the risk of a prolonged liquidity drought.
Worst-Case Scenario involves a failure to secure a foundational project contract within the next 12-18 months, leading to a liquidity crisis. This could trigger a dilutive equity offering at a severely depressed price, a collapse in partner confidence, and a reassessment of the technology's commercial viability. Quantifying the downside, a break below the critical $8.85 support (52-week low) could trigger a new leg down. A realistic bear-case target could be in the $5-$7 range, representing a potential loss of 30-55% from the current $11.23 price, exacerbated by the stock's high volatility.
FAQ
The key risks are: 1) Financial/Execution Risk: Unsustainable cash burn (-$460.1M TTM) against a finite $841.5M cash runway, with revenue collapsing 94.7% YoY. 2) Commercialization Risk: Failure to secure a firm, financed order for its VOYGR plants, extending the path to profitability indefinitely. 3) Valuation & Market Risk: Extreme P/S of 73.7x leaves the stock vulnerable to severe multiple compression on any bad news, amplified by its high beta of 2.25. 4) Competitive Risk: Other SMR developers or alternative clean energy technologies may secure key projects and funding first, as seen with recent UK support for Rolls-Royce.
The 12-month forecast is highly uncertain, with three distinct scenarios. The Base Case (50% probability) sees the stock trading between $9 and $15, as the company continues development without a major order. The Bull Case (20% probability) targets $25-$35 on the back of a confirmed commercial project order. The Bear Case (30% probability) warns of a drop to $5-$8 if liquidity concerns mount and support at $8.85 fails. The most likely outcome is the volatile Base Case, as the company's fate hinges on converting interest into firm contracts, a process that may take longer than the market anticipates.
SMR is dramatically overvalued based on traditional financial metrics. With a trailing Price-to-Sales ratio of 73.7x and no earnings (forward P/E of -18.3), the market is valuing future potential, not current performance. This represents a massive premium to any established utility or energy company. The valuation can only be justified if the company successfully commercializes its technology and hits analyst revenue targets of over $1.3 billion. Currently, the stock is fairly valued only as a long-dated, high-volatility option on that future success, but fundamentally overvalued.
SMR is not a good stock to buy for most investors. It is a highly speculative, pre-revenue company with a 94.7% year-over-year revenue decline, a massive cash burn of -$460.1 million annually, and a valuation (73.7x P/S) that prices in flawless future execution. For a very risk-tolerant investor with a long-term horizon (5-10 years) who believes strongly in the SMR thesis and can afford to lose the entire investment, it represents a high-risk call option. However, given the current lack of fundamental traction and negative analyst sentiment, it is rated Hold, not Buy.
SMR is unsuitable for short-term investment due to its extreme volatility (beta 2.25), lack of near-term catalysts, and high risk of continued decline. It pays no dividend and has no earnings visibility. The investment thesis is inherently long-term, based on the multi-year timeline for SMR commercialization. If an investor believes in the technology, a minimum holding period of 3-5 years is necessary to see through the development phase. However, this is a speculative long-term hold, not a foundational investment, and should constitute only a very small portion of a diversified portfolio.